F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer

Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer

$2 million NCI grant funds research on how pancreatic cancer uses cholesterol to survive - EurekAlert!